Chemotherapy, cognitive impairment and hippocampal toxicity

Neuroscience

Volumn 309, Issue , 2015, Pages 224-232

  Dietrich, J ^a   Prust, M ^a   Kaiser, J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Chemotherapy; Cognitive dysfunction; Hippocampus; Neural progenitor cells; Neurotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE OUTCOME; BRAIN DAMAGE; BRAIN SIZE; BREAST CANCER; CANCER PATIENT; CELL METABOLISM; COGNITIVE DEFECT; CYTOTOXICITY; HUMAN; MOLECULAR MODEL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SPATIAL LEARNING; SPATIAL MEMORY; VERBAL MEMORY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HIPPOCAMPUS; MEMORY; ORGAN SIZE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; COGNITION DISORDERS; HIPPOCAMPUS; HUMANS; MEMORY; NEUROGENESIS; ORGAN SIZE;

EID: 84945483794     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.06.016     Document Type: Review

References (101)

1. Ahles T.A., Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007, 7:192-201.
2. Ahles T.A., Saykin A.J., McDonald B.C., Li Y., Furstenberg C.T., Hanscom B.S., Mulrooney T.J., Schwartz G.N., Kaufman P.A. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 2010, 28:4434-4440.
3. Ahles T.A., Root J.C., Ryan E.L. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012, 30:3675-3686.
4. Bergouignan L., Lefranc J.P., Chupin M., Morel N., Spano J.P., Fossati P. Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS ONE 2011, 6:e25349.
5. Bisen-Hersh E.B., Hineline P.N., Walker E.A. Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors. Clin Cancer Res 2013, 19:3008-3018.
6. Briones T.L., Woods J. Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications. BMC Neurosci 2011, 12:124.
7. Burgess N., Maguire E.A., O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35:625-641.
8. Burghardt N.S., Park E.H., Hen R., Fenton A.A. Adult-born hippocampal neurons promote cognitive flexibility in mice. Hippocampus 2012, 22:1795-1808.
9. Castilla-Ortega E., Pedraza C., Estivill-Torrus G., Santin L.J. When is adult hippocampal neurogenesis necessary for learning? Evidence from animal research. Rev Neurosci 2011, 22:267-283.
10. Christie L.A., Acharya M.M., Parihar V.K., Nguyen A., Martirosian V., Limoli C.L. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res 2012, 18:1954-1965.
11. Clelland C.D., Choi M., Romberg C., Clemenson G.D., Fragniere A., Tyers P., Jessberger S., Saksida L.M., Barker R.A., Gage F.H., Bussey T.J. A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science 2009, 325:210-213.
12. Collins B., MacKenzie J., Tasca G.A., Scherling C., Smith A. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-oncology 2013, 22:1517-1527.
13. Correa D.D., Hess L.M. Cognitive function and quality of life in ovarian cancer. Gynecol Oncol 2012, 124:404-409.
14. Correa D.D., DeAngelis L.M., Shi W., Thaler H.T., Lin M., Abrey L.E. Cognitive functions in low-grade gliomas: disease and treatment effects. J Neurooncol 2007, 81:175-184.
15. Correa D.D., Maron L., Harder H., Klein M., Armstrong C.L., Calabrese P., Bromberg J.E., Abrey L.E., Batchelor T.T., Schiff D. Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol 2007, 18:1145-1151.
16. Correa D.D., Shi W., Abrey L.E., Deangelis L.M., Omuro A.M., Deutsch M.B., Thaler H.T. Cognitive functions in primary CNS lymphoma after single or combined modality regimens. Neuro-oncology 2012, 14:101-108.
17. de Ruiter M.B., Reneman L., Boogerd W., Veltman D.J., van Dam F.S., Nederveen A.J., Boven E., Schagen S.B. Cerebral hyporesponsiveness and cognitive impairment 10years after chemotherapy for breast cancer. Hum Brain Mapp 2011, 32:1206-1219.
18. Deng W., Aimone J.B., Gage F.H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?. Nat Rev Neurosci 2010, 11:339-350.
19. Dietrich J., Han R., Yang Y., Mayer-Proschel M., Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006, 5:22.
20. Dietrich J., Monje M., Wefel J., Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 2008, 13:1285-1295.
21. Dietrich J., Norden A.D., Wen P.Y. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues. Curr Opin Neurol 2008, 21:736-744.
22. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remission?. Science 2012, 338:72-75.
23. Ekstrom A.D., Kahana M.J., Caplan J.B., Fields T.A., Isham E.A., Newman E.L., Fried I. Cellular networks underlying human spatial navigation. Nature 2003, 425:184-188.
24. El M., Mustafa S., Umka J., Lyons L., Salman A., Dormon K., Allcock C., Bennett G., Wigmore P. The effect of 5-fluorouracil on the long term survival and proliferation of cells in the rat hippocampus. Brain Res Bull 2012, 88:514-518.
25. ElBeltagy M., Mustafa S., Umka J., Lyons L., Salman A., Chur-yoe G.T., Bhalla N., Bennett G., Wigmore P.M. Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behav Brain Res 2010, 208:112-117.
26. Evenden J. Cognitive impairments and cancer chemotherapy: translational research at a crossroads. Life Sci 2013, 93:589-595.
27. Fardell J.E., Vardy J., Shah J.D., Johnston I.N. Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology 2012, 220:183-193.
28. Fardell J.E., Vardy J., Johnston I.N. The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory. Life Sci 2013, 93:596-604.
29. Ferguson R.J., McDonald B.C., Saykin A.J., Ahles T.A. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 2007, 25:3866-3870.
30. Foley J.J., Raffa R.B., Walker E.A. Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology 2008, 199:527-538.
31. Genschaft M., Huebner T., Plessow F., Ikonomidou V.N., Abolmaali N., Krone F., Hoffmann A., Holfeld E., Vorwerk P., Kramm C., Gruhn B., Koustenis E., Hernaiz-Driever P., Mandal R., Suttorp M., Hummel T., Ikonomidou C., Kirschbaum C., Smolka M.N. Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS ONE 2013, 8:e78599.
32. Han R., Yang Y.M., Dietrich J., Luebke A., Mayer-Proschel M., Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol 2008, 7:12.
33. Hermelink K., Untch M., Lux M.P., Kreienberg R., Beck T., Bauerfeind I., Munzel K. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007, 109:1905-1913.
34. Horky L.L., Gerbaudo V.H., Zaitsev A., Plesniak W., Hainer J., Govindarajulu U., Kikinis R., Dietrich J. Systemic chemotherapy decreases brain glucose metabolism. Ann Clin Transl Neurol 2014, 1:788-798.
35. Inagaki M., Yoshikawa E., Matsuoka Y., Sugawara Y., Nakano T., Akechi T., Wada N., Imoto S., Murakami K., Uchitomi Y. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007, 109:146-156.
36. Janelsins M.C., Roscoe J.A., Berg M.J., Thompson B.D., Gallagher M.J., Morrow G.R., Heckler C.E., Jean-Pierre P., Opanashuk L.A., Gross R.A. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest 2010, 28:544-553.
37. Janelsins M.C., Kohli S., Mohile S.G., Usuki K., Ahles T.A., Morrow G.R. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 2011, 38:431-438.
38. Jenkins V., Beveridge H., Low R., Mitra S. Atypical hearing loss in women with breast cancer receiving adjuvant treatment. Breast 2006, 15:448-451.
39. Kaiser J., Bledowski C., Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex 2014, 54:33-50.
40. Kaya E., Keskin L., Aydogdu I., Kuku I., Bayraktar N., Erkut M.A. Oxidant/antioxidant parameters and their relationship with chemotherapy in Hodgkin's lymphoma. J Int Med Res 2005, 33:687-692.
41. Kempermann G. The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?. Trends Neurosci 2008, 31:163-169.
42. Kempermann G. Seven principles in the regulation of adult neurogenesis. Eur J Neurosci 2011, 33:1018-1024.
43. Kempermann G., Fabel K., Ehninger D., Babu H., Leal-Galicia P., Garthe A., Wolf S.A. Why and how physical activity promotes experience-induced brain plasticity. Front Neurosci 2010, 4:189.
44. Kennedy D.D., Ladas E.J., Rheingold S.R., Blumberg J., Kelly K.M. Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer 2005, 44:378-385.
45. Kesler S.R., Bennett F.C., Mahaffey M.L., Spiegel D. Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res 2009, 15:6665-6673.
46. Kesler S., Janelsins M., Koovakkattu D., Palesh O., Mustian K., Morrow G., Dhabhar F.S. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behav Immun 2013, 30:S109-S116.
47. King J.A., Burgess N., Hartley T., Vargha-Khadem F., O'Keefe J. Human hippocampus and viewpoint dependence in spatial memory. Hippocampus 2002, 12:811-820.
48. Knoth R., Singec I., Ditter M., Pantazis G., Capetian P., Meyer R.P., Horvat V., Volk B., Kempermann G. Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100years. PLoS ONE 2010, 5:e8809.
49. Koppelmans V., de Ruiter M.B., van der Lijn F., Boogerd W., Seynaeve C., van der Lugt A., Vrooman H., Niessen W.J., Breteler M.M., Schagen S.B. Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat 2012, 132:1099-1106.
50. Kreukels B.P., van Dam F.S., Ridderinkhof K.R., Boogerd W., Schagen S.B. Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clin Breast Cancer 2008, 8:80-87.
51. Lacefield C.O., Itskov V., Reardon T., Hen R., Gordon J.A. Effects of adult-generated granule cells on coordinated network activity in the dentate gyrus. Hippocampus 2012, 22:106-116.
52. Lau B.W., Yau S.Y., Lee T.M., Ching Y.P., Tang S.W., So K.F. Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption. NeuroReport 2009, 20:371-377.
53. Lepage C., Smith A.M., Moreau J., Barlow-Krelina E., Wallis N., Collins B., MacKenzie J., Scherling C. A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. SpringerPlus 2014, 3:444.
54. Licht T., Goshen I., Avital A., Kreisel T., Zubedat S., Eavri R., Segal M., Yirmiya R., Keshet E. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci USA 2011, 108:5081-5086.
55. Liedke P.E., Reolon G.K., Kilpp B., Brunetto A.L., Roesler R., Schwartsmann G. Systemic administration of doxorubicin impairs aversively motivated memory in rats. Pharmacol Biochem Behav 2009, 94:239-243.
56. Long J.M., Lee G.D., Kelley-Bell B., Spangler E.L., Perez E.J., Longo D.L., de Cabo R., Zou S., Rapp P.R. Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats. Pharmacol Biochem Behav 2011, 100:205-211.
57. Lopez Zunini R.A., Scherling C., Wallis N., Collins B., MacKenzie J., Bielajew C., Smith A.M. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav 2013, 7:460-477.
58. Lucassen P.J., Meerlo P., Naylor A.S., van Dam A.M., Dayer A.G., Fuchs E., Oomen C.A., Czeh B. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur Neuropsychopharmacol 2010, 20:1-17.
59. Lyons L., Elbeltagy M., Bennett G., Wigmore P. The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat. PLoS ONE 2011, 6:e21445.
60. Lyons L., ElBeltagy M., Bennett G., Wigmore P. Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery. PLoS ONE 2012, 7:e30010.
61. McDonald B.C., Conroy S.K., Ahles T.A., West J.D., Saykin A.J. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat 2010, 123:819-828.
62. Mignone R.G., Weber E.T. Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA. Brain Res 2006, 1111:26-29.
63. Mondie C.M., Vandergrift K.A., Wilson C.L., Gulinello M.E., Weber E.T. The chemotherapy agent, thioTEPA, yields long-term impairment of hippocampal cell proliferation and memory deficits but not depression-related behaviors in mice. Behav Brain Res 2010, 209:66-72.
64. Monje M., Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res 2012, 227:376-379.
65. Monje M., Thomason M.E., Rigolo L., Wang Y., Waber D.P., Sallan S.E., Golby A.J. Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia. Pediatr Blood Cancer 2013, 60:293-300.
66. Mustafa S., Walker A., Bennett G., Wigmore P.M. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 2008, 28:323-330.
67. Noble M., Mayer-Proschel M., Li Z., Dong T., Cui W., Proschel C., Ambeskovic I., Dietrich J., Han R., Yang Y.M., Folts C., Stripay J., Chen H.Y., Stevens B.M. Redox biology in normal cells and cancer: restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radic Biol Med 2015, 79C:300-323.
68. Nokia M.S., Anderson M.L., Shors T.J. Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain. Eur J Neurosci 2012, 36:3521-3530.
69. Papageorgiou M., Stiakaki E., Dimitriou H., Malliaraki N., Notas G., Castanas E., Kalmanti M. Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies. Leuk Res 2005, 29:11-16.
70. Pereira Dias G., Hollywood R., Bevilaqua M.C., da Luz A.C., Hindges R., Nardi A.E., Thuret S. Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms. Neuro-oncology 2014, 16:476-492.
71. Reiriz A.B., Reolon G.K., Preissler T., Rosado J.O., Henriques J.A., Roesler R., Schwartsmann G. Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice. Clin Cancer Res 2006, 12:5000. author reply 5000-5001.
72. Richard G.R., Titiz A., Tyler A., Holmes G.L., Scott R.C., Lenck-Santini P.P. Speed modulation of hippocampal theta frequency correlates with spatial memory performance. Hippocampus 2013, 23:1269-1279.
73. Schagen S.B., Muller M.J., Boogerd W., Mellenbergh G.J., van Dam F.S. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006, 98:1742-1745.
74. Seib D.R., Martin-Villalba A. Neurogenesis in the normal ageing hippocampus: a mini-review. Gerontology 2014, [Epub ahead of print].
75. Seigers R., Fardell J.E. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 2011, 35:729-741.
76. Seigers R., Schagen S.B., Beerling W., Boogerd W., van Tellingen O., van Dam F.S., Koolhaas J.M., Buwalda B. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav Brain Res 2008, 186:168-175.
77. Seigers R., Schagen S.B., Coppens C.M., van der Most P.J., van Dam F.S., Koolhaas J.M., Buwalda B. Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav Brain Res 2009, 201:279-284.
78. Seigers R., Pourtau L., Schagen S.B., van Dam F.S., Koolhaas J.M., Konsman J.P., Buwalda B. Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull 2010, 81:472-476.
79. Seigers R., Timmermans J., van der Horn H.J., de Vries E.F., Dierckx R.A., Visser L., Schagen S.B., van Dam F.S., Koolhaas J.M., Buwalda B. Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res 2010, 207:265-272.
80. Seigers R., Schagen S.B., Van Tellingen O., Dietrich J. Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav 2013, 7:453-459.
81. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K., Temple S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 2004, 304:1338-1340.
82. Shors T.J., Miesegaes G., Beylin A., Zhao M., Rydel T., Gould E. Neurogenesis in the adult is involved in the formation of trace memories. Nature 2001, 410:372-376.
83. Simo M., Rifa-Ros X., Rodriguez-Fornells A., Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev 2013, 37:1311-1321.
84. Spalding K.L., Bergmann O., Alkass K., Bernard S., Salehpour M., Huttner H.B., Bostrom E., Westerlund I., Vial C., Buchholz B.A., Possnert G., Mash D.C., Druid H., Frisen J. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013, 153:1219-1227.
85. Squire L.R., Ojemann J.G., Miezin F.M., Petersen S.E., Videen T.O., Raichle M.E. Activation of the hippocampus in normal humans: a functional anatomical study of memory. Proc Natl Acad Sci USA 1992, 89:1837-1841.
86. Tanaka S., Louis D.N., Curry W.T., Batchelor T.T., Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?. Nat Rev Clin Oncol 2013, 10:14-26.
87. Vardy J., Rourke S., Tannock I.F. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007, 25:2455-2463.
88. Villeda S.A., Luo J., Mosher K.I., Zou B., Britschgi M., Bieri G., Stan T.M., Fainberg N., Ding Z., Eggel A., Lucin K.M., Czirr E., Park J.S., Couillard-Despres S., Aigner L., Li G., Peskind E.R., Kaye J.A., Quinn J.F., Galasko D.R., Xie X.S., Rando T.A., Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011, 477:90-94.
89. Walker E.A., Foley J.J., Clark-Vetri R., Raffa R.B. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology 2011, 217:539-548.
90. Wefel J.S., Schagen S.B. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012, 12:267-275.
91. Weijl N.I., Hopman G.D., Wipkink-Bakker A., Lentjes E.G., Berger H.M., Cleton F.J., Osanto S. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998, 9:1331-1337.
92. Wigmore P. The effect of systemic chemotherapy on neurogenesis, plasticity and memory. Curr Top Behav Neurosci 2013, 15:211-240.
93. Wilson C.L., Weber E.T. Chemotherapy drug thioTEPA exacerbates stress-induced anhedonia and corticosteroid responses but not impairment of hippocampal cell proliferation in adult mice. Behav Brain Res 2013, 236:180-185.
94. Winocur G., Vardy J., Binns M.A., Kerr L., Tannock I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006, 85:66-75.
95. Winocur G., Becker S., Luu P., Rosenzweig S., Wojtowicz J.M. Adult hippocampal neurogenesis and memory interference. Behav Brain Res 2012, 227:464-469.
96. Winocur G., Henkelman M., Wojtowicz J.M., Zhang H., Binns M.A., Tannock I.F. The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res 2012, 18:3112-3121.
97. Wu L.M., Diefenbach M.A., Gordon W.A., Cantor J.B., Cherrier M.M. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study. Urol Oncol 2013, 31:1533-1538.
98. Yang M., Kim J.S., Song M.S., Kim S.H., Kang S.S., Bae C.S., Kim J.C., Wang H., Shin T., Moon C. Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits. Neurobiol Learn Mem 2010, 93:487-494.
99. Yang M., Kim J.S., Kim J., Kim S.H., Kim J.C., Kim J., Wang H., Shin T., Moon C. Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro. Biochem Pharmacol 2011, 82:72-80.
100. Yang M., Kim J.S., Kim J., Jang S., Kim S.H., Kim J.C., Shin T., Wang H., Moon C. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer. Brain Res Bull 2012, 89:50-56.
101. Yoshikawa E., Matsuoka Y., Inagaki M., Nakano T., Akechi T., Kobayakawa M., Fujimori M., Nakaya N., Akizuki N., Imoto S., Murakami K., Uchitomi Y. No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat 2005, 92:81-84.